Search Results for: Understanding%2BChronic%2B

Uniting for Change: Gastroparesis Awareness Month 2025 Encourages Community Advocacy

IFFGD will raise awareness for Gastroparesis during August to shed light on those impacted and how to advocate as a community MOUNT PLEASANT, S.C., July 8, 2025 /PRNewswire/ — This August, during Gastroparesis Awareness Month, patients, caregivers, healthcare professionals, and advocates across the country are coming together under the theme “Advocating for Gastroparesis” to raise awareness, support one another, and […]

Read More »

Cannabinoid Hyperemesis Syndrome Part 2

Cannabinoid Hyperemesis Syndrome (CHS) In this episode of 5 Minutes in GI, we sit down with Dr. Thangam Venkatesan and Dr. Benjamin Liu to discuss Cannabinoid Hyperemesis Syndrome (CHS). The original video has been split into two parts to make the content easily digestible (pun intended). This is part 2: Understanding CHS and Its Connection […]

Read More »

Robin’s Personal Story

Robin’s Personal Story-Incontinence I am now a 69 year old male living in a small town in Cumbria. Born in Edinburgh in 1955.I cannot remember a time when I was not in a nappy and plastic pants. I was born with a genetic malformation of the bladder that as I grew necessitated visits to consultants […]

Read More »

2025 IBS Awareness Month: More Than Just a Stomachache

International Foundation for Gastrointestinal Disorders (IFFGD) launches #MoreThanAStomachache, a social campaign Raising Awareness About the Real Impact of IBS.  MOUNT PLEASANT, S.C., March 6, 2025 /PRNewswire/ — Irritable bowel syndrome (IBS) affects up to 5-10% of individuals worldwide, making it one of the most common gastrointestinal disorders. Although IBS does not shorten a person’s life span, living with IBS presents a myriad of challenges […]

Read More »

Overview of The FDA

Overview Of The FDA, Emily Taylor What does the U.S. Food and Drug Administration (FDA) really do? In this presentation, Emily Taylor provides an overview of the FDA’s role, responsibilities, and impact on public health. Learn about the FDA’s history and timeline, how it is funded, and what products and industries it regulates. This session […]

Read More »

What is Cannabinoid Hyperemesis Syndrome (CHS)? Part 1

Cannabinoid Hyperemesis Syndrome (CHS) In this episode of 5 Minutes in GI, we sit down with Dr. Thangam Venkatesan and Dr. Benjamin Liu to discuss Cannabinoid Hyperemesis Syndrome (CHS). The original video has been split into two parts to make the content easily digestible (pun intended). Understanding CHS and Its Connection to CVS Cannabinoid Hyperemesis […]

Read More »
Skip to content